Business Wire Dermavant Announces $200 Million of Financing
6.7.21
BUSINESS WIRE Mycovia Pharmaceuticals Submits New Drug Application to the U.S. FDA for Oteseconazole for the Treatment of Recurrent Vulvovaginal Candidiasis
6.1.21
business wire Argenta Enters $30 Million Product Financing Agreement with NovaQuest to Accelerate New Veterinary Product Development
5.20.21
BUSINESS WIRE Aceragen Launches with Acquisition of Enzyvant‘s Investigational Therapy for Farber Disease and $35 Million Product Financing with NovaQuest
5.3.21
Yahoo Finance Cerevel Therapeutics Announces Strategic $125 Million Non-Dilutive Financing Transaction for Tavapadon
4.13.21
BUSINESS WIRE Pro-ficiency to Accelerate Growth with Major Investment from NovaQuest Private Equity
2.23.21
BUSINESS WIRE NovaQuest Private Equity Acquires CoreRx, Inc.
1.19.21
Reuters Italy’s healthcare group Angelini buys Swiss-based Arvelle in $1 billion deal
1.4.21
BUSINESS WIRE Mycovia Pharmaceuticals Announces Positive Topline Results from Phase 3 VIOLET Studies of Oteseconazole in Patients with Recurrent Vulvovaginal Candidiasis
12.9.20
Yahoo News NovaQuest Capital invests in Mileutis’ animal health products
10.19.20